RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Taiko Pharmaceutical Co Stock

Taiko Pharmaceutical Co P/S 2024

Taiko Pharmaceutical Co P/S

2.78

Ticker

4574.T

ISIN

JP3442200006

As of Sep 6, 2024, Taiko Pharmaceutical Co's P/S ratio stood at 2.78, a -47.05% change from the 5.25 P/S ratio recorded in the previous year.

The Taiko Pharmaceutical Co P/S history

Taiko Pharmaceutical Co Aktienanalyse

What does Taiko Pharmaceutical Co do?

Taiko Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Taiko Pharmaceutical Co's P/S Ratio

Taiko Pharmaceutical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Taiko Pharmaceutical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Taiko Pharmaceutical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Taiko Pharmaceutical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Taiko Pharmaceutical Co stock

What is the price-to-earnings ratio of Taiko Pharmaceutical Co?

The price-earnings ratio of Taiko Pharmaceutical Co is currently 2.78.

How has the price-earnings ratio of Taiko Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Taiko Pharmaceutical Co has increased by -47.05% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Taiko Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Taiko Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Taiko Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Taiko Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Taiko Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Taiko Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Taiko Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Taiko Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Taiko Pharmaceutical Co pay?

Over the past 12 months, Taiko Pharmaceutical Co paid a dividend of 23.67 JPY . This corresponds to a dividend yield of about 5.84 %. For the coming 12 months, Taiko Pharmaceutical Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Taiko Pharmaceutical Co?

The current dividend yield of Taiko Pharmaceutical Co is 5.84 %.

When does Taiko Pharmaceutical Co pay dividends?

Taiko Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, January.

How secure is the dividend of Taiko Pharmaceutical Co?

Taiko Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Taiko Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Taiko Pharmaceutical Co located?

Taiko Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Taiko Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Taiko Pharmaceutical Co from 3/31/2021 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 12/29/2020.

When did Taiko Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/31/2021.

What was the dividend of Taiko Pharmaceutical Co in the year 2023?

In the year 2023, Taiko Pharmaceutical Co distributed 0 JPY as dividends.

In which currency does Taiko Pharmaceutical Co pay out the dividend?

The dividends of Taiko Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Taiko Pharmaceutical Co

Our stock analysis for Taiko Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Taiko Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.